Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 2 Insulin Resistance 1

Interventions

licogliflozin 1 Metformin 1 DLBS3233 1 Clomiphene 1 Cholecalciferol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Insulin Resistance × DLBS3233 × Clear all

NCT01999686 2019-05-28

POSITIF

Dexa Medica Group

Phase 3 Completed

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡